INTRODUCTION
Dolichol phosphate mannose (Dol-P-Man) is a central donor of activated mannoses for several glycosylation pathways. It participates in N-glycosylation of proteins, a pathway highly conserved among eukaryotes, by donating the last four mannosyl residues during the synthesis of the lipid-linked precursor oligosaccharide Dol-PP-GlcNAc # Man * Glc $ [1] . N-glycosylation plays an important role in protein folding and quality control in the endoplasmic reticulum (ER) and is crucial for biosynthetic trafficking of proteins beyond the ER and throughout the secretory pathway [2] . In fungi such as yeast, Dol-P-Man supplies the first mannosyl residue that is O-glycosidically linked to protein [3, 4] . It also is the mannose donor in the biosynthesis of glycosylphosphatidylinositol (GPI) membrane anchors [5] . This mechanism of anchoring protein in plasma membranes was first described in T. brucei [6, 7] and, like N-glycosylation, has since been shown to be ubiquitous among eukaryotes. There is a growing body of evidence that these GPI anchors exhibit a variety of functions other than the mere anchoring of membrane proteins (reviewed in [8] ) and in Plasmodium falciparum, the causative agent of malaria tropica, evidence has emerged that the Abbreviations used : CEF, secondary chicken embryo fibroblasts ; Dol-P, dolichol phosphate ; Dol-P-Man, dolichol phosphate mannose ; ER, endoplasmic reticulum ; GPI, glycosylphosphatidylinositol ; ts, temperature-sensitive. * This work is dedicated to Dr. P. W. Robbins on the occasion of his 65th birthday, to whom R. T. Schwarz is particularly thankful for stimulating his interest in glycoconjugate biosynthesis.
§ To whom correspondence should be addressed. The nucleotide sequence reported will appear in DDBJ, EMBL and GenBank Nucleotide Sequence Databases under the accession number Z54162.
stretch of five nucleotides immediately upstream from the putative initiation codon that could function as a prokaryotic ribosome binding site. A consensus sequence for dolichol binding (FI\VXF\YXXIPFXF\Y) found in the yeast protein could not be detected in the putative transmembrane domain of the T. brucei sequence. Biochemical characterization of the recombinant protein showed that it is functionally expressed in the yeast strain DPM 1-6 and Escherichia coli. In both constructs Dol-P-Man synthesis was shown in a cell-free system. Synthesis was stimulated by exogenous dolichol phosphate and inhibited by amphomycin. These results confirm that we have cloned the T. brucei Dol-P-Man synthase by heterologous complementation in yeast, an approach that might be applicable for other glycosyltransferases from various sources.
GPI moiety of merozoite surface proteins is a major fever toxin and might be responsible for exacerbating the effects of cerebral malaria [9, 10] . Dol-P-Man synthase (EC 2.4.1.83), which synthesizes Dol-PMan from GDP-Man and dolichol phosphate (Dol-P), plays a crucial role in these three pathways, which take place in the ER. The topology of Dol-P-Man biosynthesis and its further involvement in protein glycosylation is in itself an interesting problem because synthesis and utilization of this mannose donor apparently occur on opposite sides of the ER membrane [11, 12] . The enzyme from T. brucei has been co-localized with ER markers [13] , and the enzyme from yeast has been purified [14] . The yeast enzyme has been cloned and sequenced by Orlean et al. [15] from a temperature-sensitive (ts) yeast mutant, and it was shown that it is indeed an essential protein involved in N-,O-glycosylation and GPI anchor synthesis in yeast [4] . Furthermore they were able to complement glycosylation defects in mammalian cell lines with the cloned yeast gene [16, 17] .
Because glycosylation is a hallmark of surface proteins, these biosynthetic pathways play a particularly interesting role in the biology of parasites as surface antigens and their carbohydrate structures have to interact with the immune system of the host.
In parasitic protozoans such as trypanosomes the anchoring of surface proteins through GPI anchors seems to be more widespread than in higher eukaryotes [18] , thus making Nglycosylation and GPI anchor synthesis crucial for parasite survival. Taking into account the enormous medical and economical impact of protozoan parasites, there is a clear need to gain more knowledge about the enzymes involved in these pathways. Through recombinant DNA technology it should be possible to clone, express and subsequently characterize these enzymes, which are not readily accessible owing to the often limited availability of parasite material. It should be particularly interesting to elucidate key biochemical parameters as well as susceptibility towards inhibitors for these enzymes, especially in comparison with their mammalian counterparts, because further knowledge about these structures and their biosynthesis could have a profound impact on the development of vaccines and new antiparasitic drugs.
Because up-to-date sequence information on most of the enzymes involved in protein glycosylation is very limited it seems difficult to make assessments about conservation at the sequence level, although these proteins are conserved functionally across taxa.
We therefore decided to clone and characterize the Dol-P-Man synthase from T. brucei, an essential enzyme in protein glycosylation, by using the approach of heterologous complementation in yeast. Here we report the cloning and sequencing of the T. brucei Dol-P-Man synthase, the features of the deduced amino acid sequence and the result that the protozoan enzyme can be expressed in an active form by yeast and Escherichia coli. 
MATERIALS AND METHODS

Chemicals
Strains and media
The following Saccharomyces cere isiae and E. coli strains were used in this work. The ts yeast strain dpm1-6 [Mat a ; dpm1 : :Leu2 ; leu2-3,112 ; lys2-801 ; trp1-1 ; ura3-52 ;] and E. coli DH5α harbouring the plasmid pDM6, which contains the structural gene (DPM1) for the yeast Dol-P-Man synthase, were a gift from Dr. P. Orlean [15] . YPH 499 [Mat a ; ura3-52 ; lys2-801 amber ; ade2-101 ochre ; trp1-∆63 ; his3-∆200 ; leu2-∆1] (Stratagene) [19] was used as a ' wild-type control ' in respect of Dol-P-Man synthase activity. E. coli strain XL1-blue (Stratagene) was used for subcloning and other standard recombinant DNA procedures. S. cere isiae strains were grown in YPAD medium [1 % (w\v) Bacto yeast extract, 2 % (w\v) Bactopeptone, 2 % (w\v) dextrose, 4 mg\l adenine] or SD medium (0.17 % Bacto yeast nitrogen base and 2 % dextrose containing the nutritional supplements necessary to complement strain auxotrophies or allow selection of transformants). E. coli strains were grown in Luria-Bertani medium supplemented with ampicillin (100 µg\ml) when necessary.
Trypanosomes
Trypanosoma b. brucei of the Molteno Institute trypanozoon antigenic type 1.4 (variant clone 118) of T. B. strain 427 were purified from infected rat blood as described [20, 21] .
Recombinant DNA methods
All standard DNA techniques were performed as described by Sambrook et al. [22] unless otherwise stated. Plasmid isolation from E. coli was routinely performed with Quiaprep columns (Quiagen). Plasmid isolation from yeast followed the protocol of Hoffman and Winston [23] . Transformation of yeast was performed by the LiAc procedure [24] . Restriction fragments were separated by agarose gel electrophoresis in Tris\acetate buffer. Individual restriction fragments were isolated with the QIAquick Gel extraction Kit (Quiagen). Sequencing was performed by double-stranded dideoxy sequencing [25, 26] with the Sequenase2 sequencing Kit Version 2.0 from United States Biochemical. Computer analysis of sequence data was performed with the Heidelberg Unix Sequence Analysis Resources (HUSAR), release 3.0.
Construction of a cDNA library from T. brucei
Total RNA was prepared by the guanidinium thiocyanate\ caesium chloride method [27] . Poly(A) + RNA was isolated with the Poly(A) + Quick2 mRNA Purification Kit from Stratagene in accordance with the manufacturer's instructions. The cDNA synthesis was performed by using the Zap-cDNA synthesis kit from Stratagene for unidirectional cloning of cDNA inserts. The cDNA was ligated into the yeast expression vector pRS 416-Met [28] , which had been digested with the restriction enzymes EcoRI and XhoI. This library was then transformed into E. coli DH5α by electroporation (Electromax Gibco\BRL) and amplified.
Nucleic acid hybridization
Southern transfers were performed essentially as described [22] , with the Boehringer Digoxigenin Labeling and Detection Kit for hybridization and detection. DNA fragments were separated on a 0.8 % agarose gel in TE buffer [10 mM Tris\HCl (pH 8.0)\1 mM EDTA], followed by alkaline denaturation. Nucleic acids were transferred to positively charged nylon membranes (Boehringer), which were processed in accordance with the manufacturer's instructions. Hybridization was performed at 60 mC overnight, with digoxigenin-labelled DNA fragments as probes, followed by two washes at room temperature in 2iSSC\0.1 % SDS and two additional washes at 68 mC in 0.1iSSC\0.1 % SDS for 15 min each (1iSSC is 0.15 M NaCl\0.015 M sodium citrate). Detection of hybridization signals was then performed in accordance with the manufacturer's instructions.
Preparation of lysates for assay of Dol-P-Man synthase
Dol-P-Man synthase activity was measured in crude lysates of yeast or E. coli cells. Exponential-phase yeast cultures (15 ml grown at either 26 or 37 mC to a D '!! of 1, corresponding to 1.5i10( cells\ml) were pelleted and washed in 1.0 ml of 1 M sorbitol\1 mM EDTA, pelleted and resuspended again in 1.0 ml of 1 M sorbitol\1 mM EDTA containing Zymolyase 20000 at a final concentration of 100 µg\ml. These cell suspensions were incubated at 37 mC for 30 min, with light-microscopic control of cell wall degradation. Cells were then harvested by centrifugation (1800 g, 10 min, 4 mC) and lysed by resuspension in 200 µl of TM buffer (50 mM Tris\HCl, pH 7.5, containing 5 mM MgCl # and 0.2 % 2-mercaptoethanol).
Lysates were assayed directly for Dol-P-Man synthase activity (30 µl for each assay, corresponding to 10) cells). E. coli lysates were prepared as described in [15] . T. brucei parasites, purified from infected rat blood, were adjusted to the same cell density as the yeast cells and lysed in TM buffer.
Assay of Dol-P-Man synthase
Enzyme assays were performed as described [3] . Briefly, incubation mixtures contained 5 µl of GDP-[$H]Man (0.1 mCi\ml ; 0.5 µCi), 8 µl of Dol-P (2 mg\ml dispersed in 0.5 % Triton X-100 by sonication), amphomycin (final concentration 1 mg\ml in some samples) and water to give a final volume of 70 µl. Reactions were started by the addition of 30 µl of cell lysates and incubated at 37 mC (the non-permissive temperature) for 10 min. Incubations were terminated after 10 min by the addition of 2 ml of ice-cold chloroform\methanol (2 : 1, v\v) and centrifuged (1500 g, 5 min, 4 mC). The pellet was extracted again with 500 µl of chloroform\methanol. Both chloroform\methanol phases were combined and subjected to repeated Folch washing [3] . An aliquot of the Folch-washed material was taken for determination of the radioactivity in the organic phase by scintillation counting. Samples of the radiolabelled, chloroform\methanol-extractable reaction products were analysed by TLC on Silica 60 plates (Merck) with chloroform\methanol\acetic acid\water (25 : 15 : 4 : 2, by vol.) as solvent, with Dol-P-Man prepared from chicken embryo fibroblasts as a reference [29] . Plates were screened for radioactivity with a Berthold LB 2842 Automatic TLC-Linear Analyzer.
To demonstrate the nature of the lipid-linked radioactivity, the radiolabelled material was purified by DEAE-cellulose chromatography and subjected to mild acid hydrolysis (1 M HCl, 15 min, 50 mC) as described by McDowell and Schwarz [30] . The reaction products were analysed by HPEAC chromatography (Dionex) on a Carbopack PA1 column by isocratic elution with 15 mM NaOH.
RESULTS
Isolation of a T. brucei cDNA fragment complementing the ts defect of the yeast strain DPM1-6
Our strategy to clone the Dol-P-Man synthase gene from T. brucei was the use of heterologous complementation in yeast because N-glycosylation and GPI anchor synthesis are evolutionally conserved pathways and thus the corresponding enzyme activities should be present in both organisms. The yeast strain DPM 1-6 was transformed with the T. brucei cDNA library as described in the Materials and methods section, after which 125 000 recombinant yeast clones were plated and grown at the permissive temperature of 27 mC, replica plated and incubated at the non-permissive temperature of 37 mC. Initially, 98 clones were obtained growing at 37 mC. To eliminate false positives, mainly revertants of the ts phenotype, these clones were plated on medium containing 5-fluoro-orotic acid at 27 mC to screen for loss of plasmid [31] . Colonies were then streaked out again and incubated at 37 mC. The 12 clones that lost their ability to grow at the elevated temperature were analysed further.
Recombinant plasmids were isolated, amplified in E. coli and used to retransform the ts strain DPM 1-6. One of these clones (clone pTB 28) was repeatedly able to rescue the ts phenotype of DPM 1-6 and was thus chosen for sequencing and biochemical analysis. 
Figure 2 DNA and derived amino acid sequence of the T. brucei Dol-PMan synthase gene
The predicted N-terminal cleavage point for the signal peptidase is indicated by a triangle ; the potential C-terminal transmembrane domain is underlined. The potential phosphorylation site (Arg-Arg-Phe-Ile-Ser) is underlined twice and the DNA sequence AAGGA, which could serve as a prokaryotic ribosome binding site, is marked with asterisks.
Sequence analysis of the T. brucei Dol-P-Man synthase gene
Restriction analysis of clone pTB 28 revealed a cDNA insert of 1.3 kb. Figure 1 shows the physical map of the insert with the restriction sites used for subcloning. The DNA sequences of both strands were determined by double-strand sequencing after generation of subclones in SK vectors. For regions that were not readily accessible by standard subcloning, specific DNA primers were synthesized to span those gaps.
Figure 3 Hydrophobicity plot of the deduced protein sequence of clone pTB 28
In this graphic presentation, a hydrophobicity index above 1.6 defines potential transmembrane domains. For this analysis a window of 9 was used.
An open reading frame of 801 base pairs was identified revealing a protein sequence of 267 amino acids with a calculated molecular mass of 29 559 kDa and an isoelectric point of 8.51. Figure 2 shows the cDNA and derived amino acid sequence of the putative T. brucei Dol-P-Man synthase. Computer-guided sequence analysis of the predicted protein sequence revealed an N-terminal stretch of amino acids that could serve as a signal sequence with a predicted cleavage site after amino acid residue 30 as described by Von Heijne [32] . The hydrophobic sequence at the C-terminus shows the characteristics of a transmembrane domain described by Kyte and Doolittle [33] . No consensus sequence (Asn-Xaa-Ser\Thr) for N-glycosylation was detected.
The sequence also contains a putative phosphorylation sequence for cAMP-dependent protein kinase around Ser-145. The amino acid sequence surrounding this serine fulfils the requirements for such a consensus sequence [34] .
The T. brucei cDNA clone does not contain the postulated ' dolichol recognition sequence ' FI\VXF\YXXIPFXF\Y [35, 36] which, in the yeast sequence, is located in the C-terminal transmembrane domain. The putative membrane-spanning region of the T. brucei C-terminus does not contain a stretch of 11 amino acids resembling this consensus. An isoleucine that has been found at position 7 in all consensus sequences so far, and has thus been postulated to be invariant, is not present in the putative transmembrane domain of the T. brucei Dol-P-Man synthase. Direct sequence comparison between the yeast and the T. brucei protein sequence shows an identity of 49 % and a similarity of 69 %, placing the putative phosphorylation site at an identical position. The hydrophobicity plot of pTB 28 ( Figure  3) shows an identical distribution of hydrophobic and hydrophilic regions for the yeast and the T. brucei protein, which becomes strikingly apparent when both plots are superimposed.
Southern blot analysis of clone pTB 28
To confirm that the cDNA insert of clone pTB 28 is of T. brucei origin, and to obtain a preliminary assessment of the copy number, Southern blots were performed under stringent conditions as described in the Materials and methods section. When BamHI digests of genomic DNA from the protozoan parasites T. brucei, P. falciparum and Toxoplasma gondii as well as DNA from a mammalian cell line (VERO) were probed with the digoxygenin-labelled cDNA insert, a band in the upper 20 kb range could be detected with the T. brucei DNA only ( Figure  4A ). When BamHI and HindIII digests of T. brucei DNA were hybridized under the same conditions ( Figure 4B ), two bands could be detected in the HindIII digest, confirming the physical map and suggesting that the Dol-P-Man synthase is a singlecopy gene in T. brucei.
The cloned T. brucei Dol-P-Man synthase is active in yeast and E. coli lysates
The capability of the cDNA cloned from T. brucei to complement repeatedly the ts phenotype of the yeast strain DPM 1-6 strongly suggests in itself that the coding sequence does indeed represent the enzyme Dol-P-Man synthase. To confirm this hypothesis we performed enzyme assays as described in the Materials and methods section. Yeast cells were grown at the permissive temperature and lysates were assayed for Dol-P-Man synthase activity at 37 mC.
When the ts strain DPM 1-6 was assayed, only minute amounts of radioactivity could be detected in the chloroform\methanol phase. The same result was obtained with DPM 1-6 harbouring the plasmid pRS 416 Met only. The yeast strain YPH 499 and secondary chicken embryo fibroblasts (CEF) used as reference produced significant amounts of radioactivity when supplemented with external Dol-P. The ts yeast strain DPM 1-6 transformed with either pDM 6, the yeast gene, or pTB 28 produced significant amounts of chloroform\methanol-extractable radiolabelled material. The reaction could be stimulated by the addition of external Dol-P and inhibited by the addition of amphomycin, a specific inhibitor of Dol-P-Man synthase [5, 37] . A similar picture emerged when E. coli harbouring pRS 426 Met, pDM6 or pTB28 were assayed. When T. brucei lysates were assayed in the same manner, incorporation of radioactivity was obtained. The results of these assays are summarized in Table 1 .
To confirm the identity of the radiolabelled reaction products, chloroform\methanol-extractable glycolipids were analysed by TLC. Dol-P-Man from CEF was included as an internal standard. Figure 5 shows the results of these analyses. In all positive
Table 1 Summary of Dol-P-Man synthase assays performed with various constructs
Assays were performed as described in the Materials and methods section. The relative Dol-P-Man synthase activity is expressed as c.p.m. monitored in the organic phase after chloroform/methanol extraction.
Dol-P-Man synthase Source
Dolichol-P Amphomycin activity (c.p.m.)
Figure 5 TLC analysis of Dol-P-Man synthase assays
Assays and TLC analysis were performed as described in the Materials and methods section. The panels represent assays as follows : (A) DPM 1-6 harbouring the plasmid pRS 416MET ; (B) DPM 1-6 harbouring the cDNA clone pTB 28 ; (C) E. coli harbouring pRS 416 MET ; (D) E. coli harbouring clone pTB 28. Exogenous Dol-P was added in these experiments. The position of Dol-P-Man from CEF is indicated by an arrow in (B).
reactions a peak of radiolabelled material was detected, migrating with the CEF standard.
To confirm that the radioactivity in the chloroform\methanol extractable compound was mannose and thus verify the identity of the radiolabelled peak as Dol-P-Man, the reaction products were purified by DEAE-cellulose chromatography followed by mild acid hydrolysis. This treatment liberates the carbohydrate moiety from the Dol-P, which then can be analysed by HPAEC Chromatography (Dionex). Figure 6 shows the result of such an analysis for the reaction product produced by the T. brucei cDNA fragment in DPM 1-6 at 37 mC. After hydrolysis the
Figure 6 Dionex HPEAC analysis of radiolabelled carbohydrates from the Dol-P-Man synthase assay of clone pTB 28 after mild acid hydrolysis
The abbreviation used is : inj, injection peak. radioactivity co-elutes on HPAEC chromatography with an internal mannose standard, clearly demostrating that the product of these enzyme assays is Dol-P-Man and thus the open reading frame of our T. brucei cDNA clone codes for a functional Dol-P-Man synthase.
DISCUSSION
We have cloned the gene for the Trypanosoma b. brucei Dol-PMan synthase from an expression cDNA library by heterologous complementation of a ts defect in the yeast strain DPM1-6. The cDNA clone pTB 28 harbours the coding sequence for this enzyme because not only was it able to complement this defect, it was also shown to exhibit Dol-P-Man synthase activity in itro. Furthermore a direct sequence comparison with the cloned yeast gene showed a coding sequence of identical length (801 nucleotides, 267 amino acid residues) with a predicted signal sequence and a C-terminal stretch of hydrophobic amino acids that could function as a transmembrane domain. Another striking similarity is the fact that both recombinant proteins are functional in E. coli. Because E. coli is able to utilize some yeast promotors [28] , the insert might be transcribed from the MET 25 promotor of the cloning vector used. The construction of this vector also requires translation from endogenous ATG codons of cloned cDNA inserts because the βGal fusion peptide of the original pRS vector has been deleted [28] . We therefore examined the regions immediately upstream of the predicted initiation codon of the T. brucei cDNA insert and found a putative ribosome binding site (Shine-Dalgarno Sequence) [38] of the sequence AAGGA with a spacing of nine nucleotides between this sequence and the ATG codon, thus fulfilling the criteria for binding of E. coli 30 S ribosomal subunits [39, 40] .
Another issue that has to be addressed in the context of significant enzyme activity in E. coli is the presence of a putative phosphorylation site in both the yeast and the T. brucei proteins (T. brucei, residues 141-146 ; yeast, residues 136-141). Because both enzymes are active in E. coli, phosphorylation is clearly not needed for enzyme function in itself. It thus can only be speculated that this site might be used for modulation of the enzyme activity that has been discussed for the mammalian enzyme [41] . Sitedirected mutagenesis and phosphorylation in itro might therefore give more insight into the validity and relevance of this phosphorylation site.
Dol-P-Man synthase belongs to a class of enzymes that have dolichol derivatives as substrates. From sequence analyses of several such enzymes a so-called dolichol recognition sequence was identified and a consensus sequence for dolichol binding (FI\VXF\YXXIPFXF\Y) was postulated [35, 36] . This hydrophobic sequence, which is positioned within the C-terminal transmembrane domain of the yeast protein, could not be detected in the T. brucei sequence. This striking finding could be explicable in light of the finding of two groups that in the yeast Dol-P-Man synthase this sequence is not essential for enzyme activity in i o and growth. Deletion of this region decreased the enzyme activity in itro but a significant residual activity still remained that was able to allow growth of recombinant yeast clones as well as protein glycosylation in S. cere isiae [42, 43] . In contrast with these findings it was shown by Datta and Lehrman [44] that this region is essential for activity of a mammalian glycosyltransferase, the hamster GlcNAc-1-phosphate transferase, which, in contrast with the corresponding yeast enzyme, posesses two putative dolichol recognition sequences, both essential for enzyme function.
The localization or distribution of Dol-P-Man synthase in the secretory pathway is not fully understood. If the assumed luminal orientation of the enzyme is correct, both proteins lack a significant cytoplasmic tail and thus a retention signal of the KDEL or KKXX type [45, 46] . Although localization of the T. brucei enzyme in the ER has been postulated [13] , the overall distribution throughout the secretory pathway still remains unclear because proteins lacking such retention signals are believed to be transported through the secretory pathway with the bulk flow of materials. In addition, details of the topology of glycosyltransferases involved in dolichol-mediated oligosaccharide biosynthesis and subsequent protein glycosylation, including the molecular mechanisms for the translocation of lipid-linked sugars across the ER membrane, still remain speculative. If the current models for dolichol-mediated glycosylation are correct, the newly synthesized Dol-P-Man must cross the ER membrane to function as a mannose donor during Nglycosylation or GPI anchor biosynthesis. Rush and Waechter [47] showed recently that in sealed microsomal vesicles a watersoluble Dol-P-Man analogue was imported into these vesicles and that this uptake exhibited the characteristics of a proteinmediated transport, thus indicating that specific proteins might indeed be involved in the translocation of Dol-P-Man across the ER membrane. Highly purified recombinant enzymes should provide the tools for addressing these questions, for example by raising specific antibodies for high-resolution immuno-gold electronmicroscopy.
In addition to these purely biochemical approaches to enzyme function, purified enzyme preparations and assays in i o by growth inhibition could also provide valuable tools for designing new antiparasitic drugs by exploiting differences between parasite enzymes and their mammalian (human) counterparts, some of which have already been discussed for the yeast and human Dol-P-Man synthase [43] .
The results presented here demonstrate that the strategy of heterologous complementation in yeast proved to be a straightforward approach that could be exploited for other enzymes involved in protein glycosylation from various sources such as parasites, to obtain these proteins in sufficient quantities to address the questions discussed above.
